Medicis Pharmaceutical Corp. (NYSE: MRX) reported Q1 EPS of $0.60, $0.18 better than the analyst estimate of $0.42. Revenue for the quarter came in at $201.7 million versus the consensus estimate of $185.15 million.

For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.

Earnings